New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry

Veriheal

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis.

How does cannabis interact with pharmaceutical drugs?

Cannabis Life Network

Because of its broad range of effects, cannabis can cause a variety of interactions with pharmaceutical drugs. The post How does cannabis interact with pharmaceutical drugs? A drug interaction happens when two or more compounds come in contact with each other and create an effect.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

More Women Switch Out Pharmaceuticals For Medical Marijuana

The Fresh Toast

More Women Switch Out Pharmaceuticals For Medical Marijuana. The post More Women Switch Out Pharmaceuticals For Medical Marijuana appeared first on The Fresh Toast. Medical Marijuana News Endometriosis gynecology menopause pharmaceuticals prescription drugs women

Global Cannabis Pharmaceuticals Market Research Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

The Global Cannabis Pharmaceuticals Market size was estimated at USD 872.57 Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others. Botanix Pharmaceuticals. Corbus Pharmaceuticals Holdings, Inc.

Ibere Pharmaceuticals Is The Quiet SPAC

Cannabis Law Report

While other cannabis industry SPAC’s have seemed to make big splashy entrances to the market, Ibere Pharmaceuticals quietly closed on… Read More. The post Ibere Pharmaceuticals Is The Quiet SPAC first appeared on Cannabis Law Report.

Corbus Pharmaceuticals Beats Estimates For Fourth Quarter

Cannabis Law Report

Endocannabinoid drug development company Corbus Pharmaceuticals Holdings, Inc. The post Corbus Pharmaceuticals Beats Estimates For Fourth Quarter appeared first on Cannabis Law Report. NASDAQ: CRBP) reported financial results for the fourth quarter and year-end 2020.…

Virpax Pharmaceuticals Reports 2022 First Quarter Results and Recent Developments

Cannabis Law Report

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC.

MyMD Pharmaceuticals Schedules Business Update Conference Call

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More. Business Wire

Virpax Pharmaceuticals Reports 2021 Year-End Results

Cannabis Law Report

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. VIRPAX PHARMACEUTICALS, INC. –Company Advances All Pre-Clinical Programs– BERWYN, Pa.–(BUSINESS

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products. The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space.

Clever Leaves and Ethypharm Announce German Pharmaceutical Cannabis Partnership

Cannabis Law Report

Clever Leaves Partners with Leading European Pharmaceutical Company to Market EU-GMP Certified Medical Cannabis Products NEW YORK, March 17, 2021… Read More.

A2W Pharma Ltd Announces New Pharmaceutical Facility in Malta

Cannabis Law Report

MARSA, Malta–(BUSINESS WIRE)–A2W Pharma Ltd, a pharmaceutical company based in Malta, celebrates the opening of its new facility during a launch event on its premises today.

United States Cannabis Pharmaceuticals Market Research Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

The United States Cannabis Pharmaceuticals Market size was estimated at USD 168.41 Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Cannabis Pharmaceuticals Market, including.

Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition

Cannabis Law Report

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The post Jazz Pharmaceuticals Increases Guidance Based On GW Pharma Acquisition appeared first on Green Market Report.

Second Edition Pharmaceutical Cannabis Report 2021: Featuring Almirall, Bayer and Novartis Among Others – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. GW Pharmaceuticals.

Cannabis vs. Pharmaceutical Medicine: One Not Very Surprising Study

Cannabis Law Report

Users are looking for safer alternatives to opioids, antidepressants, and arthritis relief. Green Entrepreneur

Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.

GW Pharmaceuticals loses $8 million over last quarter

Cannabis Law Report

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

Former GW Pharmaceuticals CFO joins Beckley Psytech’s Board

Cannabis Law Report

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

MyMD Pharmaceuticals Subsidiary Oravax Medical Preparing to Commence Clinical Trials for Oral COVID-19 Vaccine

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc.

Algernon Pharmaceuticals Submits U.S. FDA Pre-IND Meeting Request for Psychedelic Drug DMT Clinical Research Program for Stroke

Cannabis Law Report

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

MyMD Pharmaceuticals Set to Join Russell Microcap® Index

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution effective after the US market opens on June 28, according to a preliminary list of additions posted June 4. About MyMD Pharmaceuticals, Inc.

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

Cannabis Law Report

Shares to commence trading on the Nasdaq Capital Market on April 19, 2021 under the new ticker symbol “MYMD“ Upon… Read More. Business Wire

Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

Cannabis Law Report

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion

Cannabis Law Report

The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV

Royalty Rates for Pharmaceuticals & Biotechnology, 2022 Analysis Report – Real-deal Royalty Rates, License Fees, and Milestone Payment Benchmarks – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Royalty Rates for Pharmaceuticals & Biotechnology, 9th Edition” report has been added to ResearchAndMarkets.com’s offering.

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

The C³ business develops and manufactures pharmaceutical products and is comprised of Spectrum Therapeutics GmbH, based in Neumarkt-in-der-Oberpfalz, Germany , THC Pharm GmbH The Health Concept, based in Frankfurt, Germany , and Spectrum Therapeutics Austria GmbH, based in Vienna, Austria.

Anebulo Pharmaceuticals Announces Pricing of Initial Public Offering

Cannabis Law Report

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More. Business Wire

Virpax Pharmaceuticals Enters Into CRADA With The U.S. Army Institute of Surgical Research

Cannabis Law Report

–(BUSINESS WIRE)– #pharma — Virpax ® Pharmaceuticals, Inc. About Virpax Pharmaceuticals. BERWYN, Pa.–(BUSINESS

UK: Construction begins on Sittingbourne Kent Jazz Pharmaceuticals medicinal cannabis facility

Cannabis Law Report

Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. The BBC Reports. Construction has begun on a medical cannabis manufacturing facility which will create more than 100 jobs.

Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio

Cannabis Law Report

–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I BERWYN, Pa.–(BUSINESS

MyMD Pharmaceuticals Announces New Data from Comparative Study on Lead Compound MYMD-1

Cannabis Law Report

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.

February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 billion

Cannabis Law Report

The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 … Read More. billion first appeared on Cannabis Law Report. Cannabis Law TV

Prohibition Partners (UK) Publish “The Pharmaceutical Cannabis Report”

Cannabis Law Report

Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More.

Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

Cannabis Law Report

–(BUSINESS WIRE)– #earnings — Virpax ® Pharmaceuticals, Inc. Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults.

Global Cannabis Pharmaceuticals Market (2022 to 2028) – Size, Share & Trends Analysis Report – ResearchAndMarkets.com

Cannabis Law Report

The global cannabis pharmaceuticals market size is expected to reach USD 127.1 GW Pharmaceuticals. Valeant Pharmaceuticals. Such research studies are estimated to increase the demand for cannabis in the pharmaceutical industry. Synthetic Cannabis Pharmaceuticals Overview.

Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 billion

Cannabis Law Report

The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 For those of you living under a rock here is the news. We thought we better report it along with… Read More. billion first appeared on Cannabis Law Report. Breaking News